nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—ABCC5—Adefovir Dipivoxil—hepatitis B	0.485	0.567	CbGbCtD
Alprostadil—ABCC4—Adefovir Dipivoxil—hepatitis B	0.233	0.273	CbGbCtD
Alprostadil—ABCC4—Lamivudine—hepatitis B	0.137	0.16	CbGbCtD
Alprostadil—Stiffness—Telbivudine—hepatitis B	0.00554	0.0467	CcSEcCtD
Alprostadil—Fracture—Adefovir Dipivoxil—hepatitis B	0.0043	0.0363	CcSEcCtD
Alprostadil—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.0043	0.0363	CcSEcCtD
Alprostadil—Serum creatinine increased—Entecavir—hepatitis B	0.00417	0.0351	CcSEcCtD
Alprostadil—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00407	0.0343	CcSEcCtD
Alprostadil—Influenza-like symptoms—Telbivudine—hepatitis B	0.00295	0.0248	CcSEcCtD
Alprostadil—PTGIR—blood plasma—hepatitis B	0.00262	0.226	CbGeAlD
Alprostadil—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00246	0.0207	CcSEcCtD
Alprostadil—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00235	0.0198	CcSEcCtD
Alprostadil—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00207	0.0174	CcSEcCtD
Alprostadil—Influenza like illness—Telbivudine—hepatitis B	0.00205	0.0172	CcSEcCtD
Alprostadil—Sepsis—Telbivudine—hepatitis B	0.00183	0.0154	CcSEcCtD
Alprostadil—Blood triglycerides increased—Lamivudine—hepatitis B	0.00181	0.0153	CcSEcCtD
Alprostadil—Blood creatinine increased—Entecavir—hepatitis B	0.00174	0.0147	CcSEcCtD
Alprostadil—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0017	0.0143	CcSEcCtD
Alprostadil—PTGER2—blood—hepatitis B	0.00164	0.141	CbGeAlD
Alprostadil—SLCO2B1—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00159	0.105	CbGpPWpGaD
Alprostadil—Pain in extremity—Telbivudine—hepatitis B	0.00153	0.0129	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Entecavir—hepatitis B	0.00149	0.0126	CcSEcCtD
Alprostadil—ABCC4—blood plasma—hepatitis B	0.00145	0.125	CbGeAlD
Alprostadil—Hyperglycaemia—Entecavir—hepatitis B	0.00145	0.0122	CcSEcCtD
Alprostadil—Renal failure—Entecavir—hepatitis B	0.00141	0.0119	CcSEcCtD
Alprostadil—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00138	0.0116	CcSEcCtD
Alprostadil—Haematuria—Entecavir—hepatitis B	0.00137	0.0115	CcSEcCtD
Alprostadil—Vasodilation—Lamivudine—hepatitis B	0.00135	0.0114	CcSEcCtD
Alprostadil—Vasodilation procedure—Lamivudine—hepatitis B	0.00135	0.0114	CcSEcCtD
Alprostadil—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00133	0.0112	CcSEcCtD
Alprostadil—Influenza—Telbivudine—hepatitis B	0.00132	0.0111	CcSEcCtD
Alprostadil—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00131	0.0111	CcSEcCtD
Alprostadil—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00125	0.0106	CcSEcCtD
Alprostadil—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00125	0.0105	CcSEcCtD
Alprostadil—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00123	0.0104	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00123	0.0103	CcSEcCtD
Alprostadil—SLCO2A1—Transport of organic anions—ALB—hepatitis B	0.00121	0.0803	CbGpPWpGaD
Alprostadil—Renal failure—Telbivudine—hepatitis B	0.00116	0.00976	CcSEcCtD
Alprostadil—Wheezing—Lamivudine—hepatitis B	0.00115	0.00971	CcSEcCtD
Alprostadil—SLCO3A1—Transport of organic anions—ALB—hepatitis B	0.00115	0.0761	CbGpPWpGaD
Alprostadil—Back pain—Adefovir Dipivoxil—hepatitis B	0.00106	0.00891	CcSEcCtD
Alprostadil—Hypoaesthesia—Telbivudine—hepatitis B	0.00105	0.00887	CcSEcCtD
Alprostadil—Pharyngitis—Telbivudine—hepatitis B	0.00105	0.00884	CcSEcCtD
Alprostadil—Sepsis—Lamivudine—hepatitis B	0.00103	0.00868	CcSEcCtD
Alprostadil—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00101	0.00852	CcSEcCtD
Alprostadil—PTGIR—blood—hepatitis B	0.00096	0.0827	CbGeAlD
Alprostadil—Cough—Adefovir Dipivoxil—hepatitis B	0.000954	0.00804	CcSEcCtD
Alprostadil—Injury—Lamivudine—hepatitis B	0.000937	0.0079	CcSEcCtD
Alprostadil—Infection—Entecavir—hepatitis B	0.000909	0.00766	CcSEcCtD
Alprostadil—Back pain—Telbivudine—hepatitis B	0.000891	0.0075	CcSEcCtD
Alprostadil—Skin disorder—Entecavir—hepatitis B	0.000888	0.00749	CcSEcCtD
Alprostadil—Muscle spasms—Telbivudine—hepatitis B	0.000885	0.00746	CcSEcCtD
Alprostadil—Hypoglycaemia—Lamivudine—hepatitis B	0.000883	0.00744	CcSEcCtD
Alprostadil—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000874	0.00736	CcSEcCtD
Alprostadil—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000867	0.0073	CcSEcCtD
Alprostadil—SLCO3A1—blood—hepatitis B	0.000847	0.073	CbGeAlD
Alprostadil—Dyspepsia—Entecavir—hepatitis B	0.000805	0.00678	CcSEcCtD
Alprostadil—Cough—Telbivudine—hepatitis B	0.000803	0.00677	CcSEcCtD
Alprostadil—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000786	0.00662	CcSEcCtD
Alprostadil—Discomfort—Telbivudine—hepatitis B	0.000774	0.00653	CcSEcCtD
Alprostadil—PTGIR—liver—hepatitis B	0.000751	0.0647	CbGeAlD
Alprostadil—Influenza—Lamivudine—hepatitis B	0.000745	0.00627	CcSEcCtD
Alprostadil—Thrombocytopenia—Telbivudine—hepatitis B	0.000736	0.0062	CcSEcCtD
Alprostadil—Skin disorder—Telbivudine—hepatitis B	0.00073	0.00615	CcSEcCtD
Alprostadil—Sweating increased—Lamivudine—hepatitis B	0.000725	0.00611	CcSEcCtD
Alprostadil—Abdominal pain—Entecavir—hepatitis B	0.000723	0.00609	CcSEcCtD
Alprostadil—Body temperature increased—Entecavir—hepatitis B	0.000723	0.00609	CcSEcCtD
Alprostadil—Bronchitis—Lamivudine—hepatitis B	0.000716	0.00603	CcSEcCtD
Alprostadil—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000706	0.00594	CcSEcCtD
Alprostadil—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000706	0.00594	CcSEcCtD
Alprostadil—Pollakiuria—Lamivudine—hepatitis B	0.000688	0.0058	CcSEcCtD
Alprostadil—Hyperglycaemia—Lamivudine—hepatitis B	0.000672	0.00566	CcSEcCtD
Alprostadil—SLCO2B1—Transport of organic anions—ALB—hepatitis B	0.000666	0.0441	CbGpPWpGaD
Alprostadil—SLCO3A1—liver—hepatitis B	0.000663	0.0571	CbGeAlD
Alprostadil—Dyspepsia—Telbivudine—hepatitis B	0.000661	0.00557	CcSEcCtD
Alprostadil—SLCO2A1—liver—hepatitis B	0.000656	0.0565	CbGeAlD
Alprostadil—Asthenia—Entecavir—hepatitis B	0.000656	0.00553	CcSEcCtD
Alprostadil—Renal failure—Lamivudine—hepatitis B	0.000653	0.0055	CcSEcCtD
Alprostadil—Pain—Telbivudine—hepatitis B	0.000643	0.00541	CcSEcCtD
Alprostadil—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00064	0.0054	CcSEcCtD
Alprostadil—ABCC5—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000637	0.0422	CbGpPWpGaD
Alprostadil—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000631	0.00532	CcSEcCtD
Alprostadil—Diarrhoea—Entecavir—hepatitis B	0.000626	0.00527	CcSEcCtD
Alprostadil—Sinusitis—Lamivudine—hepatitis B	0.000623	0.00525	CcSEcCtD
Alprostadil—Feeling abnormal—Telbivudine—hepatitis B	0.000619	0.00522	CcSEcCtD
Alprostadil—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000611	0.00515	CcSEcCtD
Alprostadil—Dizziness—Entecavir—hepatitis B	0.000605	0.0051	CcSEcCtD
Alprostadil—ABCC5—liver—hepatitis B	0.0006	0.0517	CbGeAlD
Alprostadil—Rhinitis—Lamivudine—hepatitis B	0.000598	0.00504	CcSEcCtD
Alprostadil—Abdominal pain—Telbivudine—hepatitis B	0.000594	0.00501	CcSEcCtD
Alprostadil—Body temperature increased—Telbivudine—hepatitis B	0.000594	0.00501	CcSEcCtD
Alprostadil—Hypoaesthesia—Lamivudine—hepatitis B	0.000593	0.005	CcSEcCtD
Alprostadil—Pharyngitis—Lamivudine—hepatitis B	0.000592	0.00498	CcSEcCtD
Alprostadil—Rash—Entecavir—hepatitis B	0.000577	0.00486	CcSEcCtD
Alprostadil—Dermatitis—Entecavir—hepatitis B	0.000576	0.00486	CcSEcCtD
Alprostadil—Headache—Entecavir—hepatitis B	0.000573	0.00483	CcSEcCtD
Alprostadil—Rash—Adefovir Dipivoxil—hepatitis B	0.000563	0.00474	CcSEcCtD
Alprostadil—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000562	0.00474	CcSEcCtD
Alprostadil—Headache—Adefovir Dipivoxil—hepatitis B	0.000559	0.00471	CcSEcCtD
Alprostadil—Nausea—Entecavir—hepatitis B	0.000543	0.00458	CcSEcCtD
Alprostadil—Asthenia—Telbivudine—hepatitis B	0.000539	0.00454	CcSEcCtD
Alprostadil—ABCC4—blood—hepatitis B	0.000532	0.0458	CbGeAlD
Alprostadil—Pruritus—Telbivudine—hepatitis B	0.000532	0.00448	CcSEcCtD
Alprostadil—Nausea—Adefovir Dipivoxil—hepatitis B	0.00053	0.00447	CcSEcCtD
Alprostadil—Erythema—Lamivudine—hepatitis B	0.000519	0.00437	CcSEcCtD
Alprostadil—Diarrhoea—Telbivudine—hepatitis B	0.000514	0.00433	CcSEcCtD
Alprostadil—Nervousness—Lamivudine—hepatitis B	0.000504	0.00425	CcSEcCtD
Alprostadil—Back pain—Lamivudine—hepatitis B	0.000502	0.00423	CcSEcCtD
Alprostadil—Muscle spasms—Lamivudine—hepatitis B	0.000499	0.0042	CcSEcCtD
Alprostadil—Dizziness—Telbivudine—hepatitis B	0.000497	0.00419	CcSEcCtD
Alprostadil—Anaemia—Lamivudine—hepatitis B	0.00048	0.00404	CcSEcCtD
Alprostadil—Rash—Telbivudine—hepatitis B	0.000474	0.00399	CcSEcCtD
Alprostadil—Dermatitis—Telbivudine—hepatitis B	0.000473	0.00399	CcSEcCtD
Alprostadil—Headache—Telbivudine—hepatitis B	0.000471	0.00397	CcSEcCtD
Alprostadil—SLCO2B1—liver—hepatitis B	0.00047	0.0405	CbGeAlD
Alprostadil—Syncope—Lamivudine—hepatitis B	0.000465	0.00392	CcSEcCtD
Alprostadil—Loss of consciousness—Lamivudine—hepatitis B	0.000456	0.00384	CcSEcCtD
Alprostadil—Cough—Lamivudine—hepatitis B	0.000453	0.00382	CcSEcCtD
Alprostadil—SLCO2A1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.00045	0.0298	CbGpPWpGaD
Alprostadil—Convulsion—Lamivudine—hepatitis B	0.00045	0.00379	CcSEcCtD
Alprostadil—Nausea—Telbivudine—hepatitis B	0.000446	0.00376	CcSEcCtD
Alprostadil—ABCC4—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000441	0.0292	CbGpPWpGaD
Alprostadil—Discomfort—Lamivudine—hepatitis B	0.000436	0.00368	CcSEcCtD
Alprostadil—Dry mouth—Lamivudine—hepatitis B	0.000432	0.00364	CcSEcCtD
Alprostadil—SLCO3A1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000426	0.0282	CbGpPWpGaD
Alprostadil—Oedema—Lamivudine—hepatitis B	0.000423	0.00357	CcSEcCtD
Alprostadil—Infection—Lamivudine—hepatitis B	0.000421	0.00354	CcSEcCtD
Alprostadil—Shock—Lamivudine—hepatitis B	0.000417	0.00351	CcSEcCtD
Alprostadil—ABCC4—liver—hepatitis B	0.000416	0.0358	CbGeAlD
Alprostadil—Thrombocytopenia—Lamivudine—hepatitis B	0.000415	0.00349	CcSEcCtD
Alprostadil—Skin disorder—Lamivudine—hepatitis B	0.000411	0.00347	CcSEcCtD
Alprostadil—Hyperhidrosis—Lamivudine—hepatitis B	0.000409	0.00345	CcSEcCtD
Alprostadil—Hypotension—Lamivudine—hepatitis B	0.000396	0.00333	CcSEcCtD
Alprostadil—Dyspepsia—Lamivudine—hepatitis B	0.000373	0.00314	CcSEcCtD
Alprostadil—Pain—Lamivudine—hepatitis B	0.000362	0.00305	CcSEcCtD
Alprostadil—Feeling abnormal—Lamivudine—hepatitis B	0.000349	0.00294	CcSEcCtD
Alprostadil—Body temperature increased—Lamivudine—hepatitis B	0.000335	0.00282	CcSEcCtD
Alprostadil—Abdominal pain—Lamivudine—hepatitis B	0.000335	0.00282	CcSEcCtD
Alprostadil—ABCC5—NRF2 pathway—GGT2—hepatitis B	0.00032	0.0212	CbGpPWpGaD
Alprostadil—Asthenia—Lamivudine—hepatitis B	0.000304	0.00256	CcSEcCtD
Alprostadil—Pruritus—Lamivudine—hepatitis B	0.0003	0.00252	CcSEcCtD
Alprostadil—Diarrhoea—Lamivudine—hepatitis B	0.00029	0.00244	CcSEcCtD
Alprostadil—Dizziness—Lamivudine—hepatitis B	0.00028	0.00236	CcSEcCtD
Alprostadil—Rash—Lamivudine—hepatitis B	0.000267	0.00225	CcSEcCtD
Alprostadil—Dermatitis—Lamivudine—hepatitis B	0.000267	0.00225	CcSEcCtD
Alprostadil—Headache—Lamivudine—hepatitis B	0.000265	0.00224	CcSEcCtD
Alprostadil—Nausea—Lamivudine—hepatitis B	0.000252	0.00212	CcSEcCtD
Alprostadil—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000247	0.0164	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—HBE1—hepatitis B	0.000223	0.0148	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—GGT2—hepatitis B	0.000222	0.0147	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—HSPA5—hepatitis B	0.000201	0.0133	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—CYP2A6—hepatitis B	0.000194	0.0128	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.000192	0.0127	CbGpPWpGaD
Alprostadil—PTGIR—Platelet homeostasis—NOS2—hepatitis B	0.000184	0.0122	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—GGT1—hepatitis B	0.000151	0.01	CbGpPWpGaD
Alprostadil—ABCC5—Fluoropyrimidine Activity—TP53—hepatitis B	0.000138	0.00912	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000136	0.00902	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—CYP2A6—hepatitis B	0.000134	0.0089	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—HBE1—hepatitis B	0.000133	0.0088	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000123	0.00817	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—GOT2—hepatitis B	0.000111	0.00734	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000106	0.007	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—GGT1—hepatitis B	0.000105	0.00695	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CXCL10—hepatitis B	0.000104	0.00687	CbGpPWpGaD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—ALB—hepatitis B	9.66e-05	0.0064	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—GOT1—hepatitis B	9.57e-05	0.00634	CbGpPWpGaD
Alprostadil—ABCC4—Fluoropyrimidine Activity—TP53—hepatitis B	9.55e-05	0.00632	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—F2—hepatitis B	9.25e-05	0.00612	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	9.2e-05	0.0061	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	9.2e-05	0.0061	CbGpPWpGaD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—ALB—hepatitis B	9.15e-05	0.00606	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	9.06e-05	0.006	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—ALB—hepatitis B	9.03e-05	0.00598	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	8.92e-05	0.00591	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—hepatitis B	8.6e-05	0.0057	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	8.33e-05	0.00552	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	8.33e-05	0.00552	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	8.27e-05	0.00548	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CCR5—hepatitis B	8.05e-05	0.00533	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RIT2—hepatitis B	7.97e-05	0.00528	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SAG—hepatitis B	7.97e-05	0.00528	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—HSPA5—hepatitis B	7.72e-05	0.00511	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	7.14e-05	0.00473	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	7.14e-05	0.00473	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CXCL10—hepatitis B	7.01e-05	0.00464	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CXCL10—hepatitis B	7.01e-05	0.00464	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IFNB1—hepatitis B	6.96e-05	0.00461	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—F2—hepatitis B	6.9e-05	0.00457	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IFNA1—hepatitis B	6.79e-05	0.0045	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SAG—hepatitis B	6.61e-05	0.00438	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOBEC3G—hepatitis B	6.61e-05	0.00438	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IFNA2—hepatitis B	6.32e-05	0.00419	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	6.12e-05	0.00406	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	6.12e-05	0.00406	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CXCL10—hepatitis B	5.86e-05	0.00388	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—TGFB1—hepatitis B	5.71e-05	0.00378	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	5.44e-05	0.0036	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCR5—hepatitis B	5.43e-05	0.0036	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCR5—hepatitis B	5.43e-05	0.0036	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RIT2—hepatitis B	5.38e-05	0.00357	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RIT2—hepatitis B	5.38e-05	0.00357	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SAG—hepatitis B	5.38e-05	0.00357	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SAG—hepatitis B	5.38e-05	0.00357	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CXCL10—hepatitis B	5.32e-05	0.00353	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—ALB—hepatitis B	5.31e-05	0.00352	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—TGFB1—hepatitis B	5.09e-05	0.00337	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKR1B1—hepatitis B	5.01e-05	0.00332	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—ALB—hepatitis B	4.91e-05	0.00325	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—F2—hepatitis B	4.82e-05	0.00319	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GGT2—hepatitis B	4.8e-05	0.00318	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—F2—hepatitis B	4.66e-05	0.00309	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—F2—hepatitis B	4.66e-05	0.00309	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—ALB—hepatitis B	4.65e-05	0.00308	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—HSPA5—hepatitis B	4.6e-05	0.00305	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—CTNNB1—hepatitis B	4.57e-05	0.00303	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CCR5—hepatitis B	4.55e-05	0.00301	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—F2—hepatitis B	4.17e-05	0.00276	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IFNB1—hepatitis B	4.15e-05	0.00275	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCR5—hepatitis B	4.13e-05	0.00274	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—NOS2—hepatitis B	4.12e-05	0.00273	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IFNA1—hepatitis B	4.05e-05	0.00268	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—ALB—hepatitis B	4e-05	0.00265	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL10—hepatitis B	3.96e-05	0.00262	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL10—hepatitis B	3.96e-05	0.00262	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—F2—hepatitis B	3.9e-05	0.00258	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IFNA2—hepatitis B	3.77e-05	0.0025	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL10—hepatitis B	3.6e-05	0.00238	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL10—hepatitis B	3.6e-05	0.00238	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—F2—hepatitis B	3.54e-05	0.00235	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—TGFB1—hepatitis B	3.53e-05	0.00234	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—ALB—hepatitis B	3.46e-05	0.00229	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	3.27e-05	0.00217	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2—hepatitis B	3.25e-05	0.00215	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL10—hepatitis B	3.15e-05	0.00208	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GOT2—hepatitis B	3.14e-05	0.00208	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR5—hepatitis B	3.07e-05	0.00203	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCR5—hepatitis B	3.07e-05	0.00203	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2A6—hepatitis B	2.91e-05	0.00193	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IL2—hepatitis B	2.81e-05	0.00186	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR5—hepatitis B	2.79e-05	0.00185	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR5—hepatitis B	2.79e-05	0.00185	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GOT1—hepatitis B	2.71e-05	0.0018	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ALB—hepatitis B	2.7e-05	0.00179	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—F2—hepatitis B	2.63e-05	0.00175	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—F2—hepatitis B	2.63e-05	0.00175	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GOT2—hepatitis B	2.63e-05	0.00174	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL2—hepatitis B	2.63e-05	0.00174	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ALB—hepatitis B	2.58e-05	0.00171	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	2.53e-05	0.00168	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—F2—hepatitis B	2.49e-05	0.00165	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS2—hepatitis B	2.46e-05	0.00163	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR5—hepatitis B	2.44e-05	0.00162	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—F2—hepatitis B	2.39e-05	0.00159	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—F2—hepatitis B	2.39e-05	0.00159	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2—hepatitis B	2.39e-05	0.00158	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GGT1—hepatitis B	2.27e-05	0.0015	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GOT1—hepatitis B	2.27e-05	0.0015	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TGFB1—hepatitis B	2.19e-05	0.00145	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL10—hepatitis B	2.12e-05	0.00141	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL10—hepatitis B	2.12e-05	0.00141	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—F2—hepatitis B	2.09e-05	0.00139	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ALB—hepatitis B	2.06e-05	0.00137	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CCR5—hepatitis B	2.02e-05	0.00134	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HLA-A—hepatitis B	1.97e-05	0.00131	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—hepatitis B	1.8e-05	0.00119	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—hepatitis B	1.79e-05	0.00118	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2—hepatitis B	1.77e-05	0.00118	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2—hepatitis B	1.77e-05	0.00118	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS2—hepatitis B	1.72e-05	0.00114	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2—hepatitis B	1.67e-05	0.00111	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR5—hepatitis B	1.65e-05	0.00109	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR5—hepatitis B	1.65e-05	0.00109	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2—hepatitis B	1.61e-05	0.00107	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2—hepatitis B	1.61e-05	0.00107	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—F2—hepatitis B	1.41e-05	0.000936	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—F2—hepatitis B	1.41e-05	0.000936	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2—hepatitis B	1.41e-05	0.000934	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—hepatitis B	1.4e-05	0.000929	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CTNNB1—hepatitis B	1.36e-05	0.000901	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1A—hepatitis B	1.33e-05	0.00088	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTEN—hepatitis B	1.33e-05	0.000878	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NFKB1—hepatitis B	1.32e-05	0.000874	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB1—hepatitis B	1.31e-05	0.000865	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD4—hepatitis B	1.27e-05	0.000842	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—hepatitis B	1.21e-05	0.0008	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CTNNB1—hepatitis B	1.13e-05	0.000748	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1A—hepatitis B	1.1e-05	0.00073	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTEN—hepatitis B	1.1e-05	0.000729	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TGFB1—hepatitis B	1.1e-05	0.000728	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—hepatitis B	1.07e-05	0.000712	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2—hepatitis B	9.52e-06	0.000631	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2—hepatitis B	9.52e-06	0.000631	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—hepatitis B	9.47e-06	0.000627	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—hepatitis B	9.47e-06	0.000627	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTEN—hepatitis B	9.21e-06	0.00061	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CTNNB1—hepatitis B	9.19e-06	0.000609	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CTNNB1—hepatitis B	9.19e-06	0.000609	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TGFB1—hepatitis B	9.12e-06	0.000604	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—hepatitis B	9.05e-06	0.000599	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1A—hepatitis B	8.98e-06	0.000595	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1A—hepatitis B	8.98e-06	0.000595	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTEN—hepatitis B	8.96e-06	0.000593	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTEN—hepatitis B	8.96e-06	0.000593	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NFKB1—hepatitis B	8.91e-06	0.00059	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NFKB1—hepatitis B	8.91e-06	0.00059	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—hepatitis B	8.28e-06	0.000549	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFB1—hepatitis B	7.43e-06	0.000492	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFB1—hepatitis B	7.43e-06	0.000492	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—hepatitis B	6.87e-06	0.000455	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—hepatitis B	6.11e-06	0.000405	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—hepatitis B	6.11e-06	0.000405	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—hepatitis B	5.6e-06	0.000371	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—hepatitis B	5.6e-06	0.000371	CbGpPWpGaD
